Warner Chilcott, a top pharmaceutical company, is reviewed in terms of partnering, licensing and M&A interests and activity over recent years.
Summary
Website: Warner Chilcott (no longer active - see Actavis)
Headquarters: Dublin, Ireland
Ticker: WCRX (Nasdaq Stock Exchange) G3LA (Frankfurt Stock Exchange) G3L (Frankfurt Stock Exchange)
SEC: Warner Chilcott
Recent deal news: Warner Chilcott deal news at Current Partnering
Must read report: Partnering Deals and Alliances with Warner Chilcott
Warner Chilcott is a top pharmaceutical company based in Dublin, Ireland.
The company was founded in 1968 as Warner-Lambert but spun out as an individual entity in 1996.
Warner Chilcott is a specialty pharmaceuticals company and is engaged in the development, manufacture, promotion, and franchise of branded pharmaceutical products.
Currently, Warner Chilcott's marketed products are concentrated in four therapeutic categories:
- Gastroenterology
- Women's health,
- Dermatology and
- Urology.
The company’s branded products are leading therapeutic products for treating ulcerative colitis, osteoporosis symptoms in women and menopausal symptoms in women.
Warner Chilcott has an active licensing venture investment and acquisition group charged with analysing and managing all incoming opportunities. Warner Chilcott has a long history of partnering, building numerous collaborative partnerships more
Warner Chilcott announced over 27 partnering / licensing deals since 2005. Analysis of the partnering deals shows a strong emphasis on partnerships in gastroenterology, menopausal medicines, followed by dermatology, and genitourinary diseases more
Warner Chilcott was acquired by Actavis Inc in May 2013.
Top 50 pharma ranking*: -
*based on reported global sale for year ending December 2013.
Key financials
Total annual revenue
Total annual R&D spend
Top selling drugs
Partnering activity
View partnering activity: 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005
Full details on each deal can be found at CurrentAgreements (subscription required)
M&A activity
View M&A activity: 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005
Full details on each deal can be found at CurrentAgreements (subscription required)
Available reports from Current Partnering
Report: Partnering Deals and Alliances with Warner Chilcott
Report: Partnering Deals and Alliances with Big Pharma
Available resources for deal coverage for Warner Chilcott
Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more
Read: more on Warner Chilcott company profile, recent partnering, M&A and financing news and articles
Related
Report: Practical Guide to Finding Partners
View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value
View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value
View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making
View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity
Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now
Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now
View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk
View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk
